Table 3.
The visual acuity (VA) difference between the treated eye and the untreated eye (treated eye is worse eye)
| ETDRS Letters |
nAMD | DMO | RVO | Other | Total | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| N | % | N | % | N | % | N | % | N | % | |
| 0–10 | 318 | 39.45 | 77 | 57.89 | 176 | 40.00 | 28 | 53.85 | 599 | 41.86 |
| 11–20 | 238 | 29.53 | 28 | 21.05 | 107 | 24.32 | 8 | 15.38 | 381 | 26.62 |
| 21–30 | 115 | 14.27 | 14 | 10.53 | 75 | 17.05 | 6 | 11.54 | 210 | 14.68 |
| 31–40 | 73 | 9.06 | 7 | 5.26 | 33 | 7.50 | 2 | 3.85 | 115 | 8.04 |
| 41–50 | 40 | 4.96 | 3 | 2.26 | 27 | 6.14 | 4 | 7.69 | 74 | 5.17 |
| 51–60 | 17 | 2.11 | 1 | 0.75 | 14 | 3.18 | 3 | 5.77 | 35 | 2.45 |
| 61–70 | 4 | 0.50 | 1 | 0.75 | 5 | 1.14 | 0.00 | 10 | 0.70 | |
| 71–85 | 1 | 0.12 | 2 | 1.50 | 3 | 0.68 | 1 | 1.92 | 7 | 0.49 |
| Total | 806 | 133 | 440 | 52 | 1431 | |||||
ETDRS Early Treatment Diabetic Retinopathy Study, nAMD neovascular age-related macular degeneration, DMO diabetic macular oedema, RVO retinal vein occlusion